PD-L1疫苗中引入不同免疫原性氨基酸对T细胞亚群分化的影响

陈红梅; 康彦良; 刘利; 姚文兵; 田浤

doi:10.11665/j.issn.1000-5048.20200313

PD-L1疫苗中引入不同免疫原性氨基酸对T细胞亚群分化的影响

中国药科大学生命科学与技术学院，江苏省生物药物成药性研究重点实验室，南京 210009

基金项目: 国家自然科学基金资助项目（No. 81573222, No. 81673343, No. 91753112）

计量
- 文章访问数: 214
- HTML全文浏览量: 3
- PDF下载量: 523
出版历程
- 收稿日期: 2020-03-22
- 修回日期: 2020-05-07
- 刊出日期: 2020-06-24

Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets

Funds: This study was supported by the National Natural Science Foundation of China (No. 81973222, No.81673343, No.91753112)

摘要

摘要: 为了比较内源性的3-硝基酪氨酸与非天然的4-硝基苯丙氨酸在PD-L1疫苗中的引入对T细胞亚群分化的影响，利用遗传密码扩充技术，将这两种免疫原性氨基酸分别引入到PD-L1疫苗的相同位点，获得具有3-硝基酪氨酸以及4-硝基苯丙氨酸的两种PD-L1突变体。用这两种突变体免疫小鼠，分析对小鼠脾脏T细胞亚群分化的影响。流式细胞术检测结果显示，4-硝基苯丙氨酸在PD-L1疫苗中的引入可促进Th1细胞的极化，同时降低Treg细胞的比例，3-硝基酪氨酸的引入对Th1细胞的极化无影响，同时能显著提高Treg和Th17细胞的比例。二者在PD-L1疫苗中的引入均能促进脾脏CD8⁺ T细胞的应答，其中含有4-硝基苯丙氨酸的PD-L1突变体应答效果更强。实验结果表明，与内源性的3-硝基酪氨酸在PD-L1疫苗中的引入相比，非天然的4-硝基苯丙氨酸更适合用于肿瘤疫苗的设计。
- PD-L1 /
- 疫苗 /
- 3-硝基酪氨酸 /
- 4-硝基苯丙氨酸 /
- T细胞亚群
Abstract: To compare the effects of endogenous 3-nitrotyrosine and non-natural 4-nitrophenylalanine in PD-L1 vaccine on the differentiation of T cell subsets, two immunogenic amino acids were introduced into the same site of PD-L1 vaccine. Two PD-L1 mutants with 3-nitrotyrosine and 4-nitrophenylalanine were obtained, respectively, using genetic code expansion technology. Mice were immunized with these two mutants, and their effects on the differentiation of T cell subsets in spleen were analyzed. The results of flow cytometry showed that the introduction of 4-nitrophenylalanine in PD-L1 vaccine could promote the polarization of Th1 cells while reducing the proportion of Treg cells; the introduction of 3-nitrotyrosine had no effect on the polarization of Th1 cells, while significantly increasing the proportion of Treg and Th17 cells. The introduction of both into PD-L1 vaccine could promote the response of CD8⁺ T cells in spleen, and the response of PD-L1 mutant containing 4-nitrophenylalanine was stronger. In summary, the non-natural 4-nitrophenylalanine is more suitable for the design of tumor vaccines as compared with endogenous 3-nitrotyrosine.
- PD-L1 /
- vaccine /
- 3-nitrotyrosine /
- 4-nitrophenylalanine /
- T cell differentiation

HTML全文

参考文献(17)

[1]	. Proc Natl Acad Sci U S A， 2008， 105（32）： 11276-11280.
[2]	Grünewald J， Hunt GS， Dong L， et al. Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids［J］. Proc Natl Acad Sci U S A， 2009， 106（11）： 4337-4342.
[3]	Khan F， Siddiqui AA. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis， osteoarthritis and systemic lupus erythematosus［J］. Clin Chim Acta， 2006， 370（1/2）： 100-107.
[4]	Khan F， Ali R. Antibodies against nitric oxide damaged poly L-tyrosine and 3-nitrotyrosine levels in systemic lupus erythematosus［J］. J Biochem Mol Biol， 2006， 39（2）： 189-196.
[5]	Thomson L， Christie J， Vadseth C， et al. Identification of immunoglobulins that recognize 3-nitrotyrosine in patients with acute lung injury after major trauma［J］. Am J Respir Cell Mol Biol， 2007， 36（2）： 152-157.
[6]	Ohmori H， Kanayama N. Immunogenicity of an inflammation-associated product， tyrosine nitrated self-proteins［J］. Autoimmun Rev， 2005， 4（4）： 224-229.
[7]	Hardy LL， Wick DA， Webb JR. Conversion of tyrosine to the inflammation-associated analog 3''''-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells［J］. J Immunol， 2008， 180（9）： 5956-5962.
[8]	He Y， Tian H， Dai X， et al. Immunogenicity of HER2 vaccine containing p-nitrophenylalanine［J］. J China Pharm Univ （中国药科大学学报）， 2018， 49（3）： 369-375.
[9]	Tian H， He Y， Song XD， et al. Nitrated T helper cell epitopes enhance the immunogenicity of HER2 vaccine and induce anti-tumor immunity［J］. Cancer Lett， 2018， 430： 79-87.
[10]	Tian H， Kang YL， Song XD， et al. PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses［J］. Cancer Lett， 2020， 476： 170-182.
[11]	Datta J， Fracol M， McMillan MT， et al. Association of depressed anti-HER2 T-helper type 1 response with recurrence in patients with completely treated HER2-positive breast cancer： role for immune monitoring［J］. JAMA Oncol， 2016， 2（2）： 242-246.
[12]	Antony PA， Piccirillo CA， Akpinarli A， et al. CD8⁺ T cell immunity against a tumor/self-antigen is augmented by CD4⁺ T helper cells and hindered by naturally occurring T regulatory cells［J］. J Immunol， 2005， 174（5）： 2591-2601.
[13]	Lakshminrusimha S， Suresh MV， Knight PR， et al. Role of pulmonary artery reactivity and nitric oxide in injury and inflammation following lung contusion［J］. Shock， 2013， 39（3）： 278-285.
[14]	Thomson L. 3-Nitrotyrosine modified proteins in atherosclerosis［J］. Dis Markers， 2015， 2015： 1-8.
[15]	Ferreira I， Croca S， Raimondo MG， et al. Nitrated nucleosome levels and neuropsychiatric events in systemic lupus erythematosus； a multi-center retrospective case-control study［J］. Arthritis Res Ther， 2017， 19（1）： 287.
[16]	Jin B， Sun T， Yu XH， et al. The effects of TLR activation on T-cell development and differentiation［J］. Clin Dev Immunol， 2012， 2012： 836485.
[17]	Li P， Spolski R， Liao W， et al. Complex interactions of transcription factors in mediating cytokine biology in T cells［J］. Immunol Rev， 2014， 261（1）： 141-156.

施引文献

资源附件(0)

计量

文章访问数: 214
HTML全文浏览量: 3
PDF下载量: 523
被引次数: 0

PD-L1疫苗中引入不同免疫原性氨基酸对T细胞亚群分化的影响

计量

出版历程

Effects of different immunogenic amino acids in PD-L1 vaccine on the differentiation of T cell subsets

计量

出版历程

目录